BVS vs TGT · rev $285.3M vs P/E 17, rev $51.98B
Bioventus Inc (BVS) versus Target Corporation (TGT) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Target Corporation (TGT) is a discount stores company listed on NYSE. It is led by Brian Cornell.
Latest reported BVS revenue for 2026-06-27 was $285.3M. Net income was $36.6M. BVS currently screens at market cap $495.1M.
Latest reported TGT revenue for 2026-08-01 was $51.98B. Net income was $2.66B. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
BVS currently screens at market cap $495.1M. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
Not investment advice. Open the BVS and TGT stock pages for the full models.
Not investment advice.